Clinical trials
Phase 1 Thyroid Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 10 |
| Active, not recruiting | 9 |
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 6 |
| National Cancer Institute (NCI) | 5 |
| M.D. Anderson Cancer Center | 3 |
| Celgene | 2 |
| Eli Lilly and Company | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Pfizer | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| University of Colorado, Denver | 2 |
| Valerio Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 50 |
| Melanoma | 22 |
| Breast Neoplasms | 18 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Pancreatic Neoplasms | 14 |
| Prostatic Neoplasms | 14 |
| Ovarian Neoplasms | 12 |
| Sarcoma | 12 |
| Urinary Bladder Neoplasms | 12 |
| Colorectal Neoplasms | 11 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.